List view / Grid view
Researchers at the University of Chicago have revealed the complete structure of adhesion GPCRs, uncovering new activation mechanisms that could lead to more targeted drug treatments.
Drug Target Review's Taylor Mixides exclusively interviews Brett Hall, Chief Scientific Officer at Immuneering, about his company’s aim to develop a universal-RAS therapy.
USC researcher Dr Steven Gazal and his team have identified human genome base pairs that have remained constant over millions of years of mammalian evolution. These base pairs are linked to human disease. Using DNA from 240 mammal species, they identified genetic variations affecting an individual's survival and reproduction.
Researchers have been able to slow down the progression of glioblastoma in mice, the most common adult brain cancer.
Researchers have developed a 3D “assembloid” that presents a potential entry route of COVID-19 into the brain.
Discovery allows scientists to index thousands of cells simultaneously, a 40-fold increase from the current method...
